Navigation Links
Chemo May Raise Risk of Falls in Breast Cancer Survivors
Date:3/4/2011

FRIDAY, March 4 (HealthDay News) -- Breast cancer survivors may be at increased risk for falls and broken bones due to the combined effects of chemotherapy and endocrine therapy, a new study suggests.

Researchers looked at 59 postmenopausal breast cancer survivors, and found that 58 percent of them had experienced a fall in the year before the start of the study and 47 percent had a fall during the six-month study period.

Those rates are much higher than the 25 percent to 30 percent annual fall rate reported for community-dwelling adults over 65 years old, noted Kerri M. Winters-Stone, an associate professor and associate scientist at Oregon Health & Science University (OHSU) School of Nursing, and colleagues.

Balance was the only difference between breast cancer survivors who fell and those who did not. The researchers said their findings also suggest that balance problems may be due to chemotherapy-related changes in the vestibular system, which is involved in balance and spatial orientation.

The study is scheduled for publication in the April issue of the Archives of Physical Medicine and Rehabilitation.

"Falls in breast cancer survivors are understudied and deserve more attention, particularly in light of the increase in fractures after breast cancer treatment and the relationship of falls to fractures," Winters-Stone, who is also a member of the OHSU Knight Cancer Institute in Portland, said in a journal news release.

"Our findings add to growing evidence that fall risk is increased in breast cancer survivors and that vestibular function may underpin associations between breast cancer treatment and falls," she added.

More information

Learn more about balance from the Vestibular Disorders Association.

-- Robert Preidt

SOURCE: Archives of Physical Medicine and Rehabilitation, news release, March 4, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New developments in nanotechnology tackle the 2 biggest problems associated with chemotherapy
2. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
3. Scientists identify microRNA as possible cause of chemotherapy resistance
4. Study evaluates costs and benefits of new chemotherapy drugs
5. Older Colon Cancer Patients Less Likely to Get Chemo
6. Are New Chemo Treatments Cost-Effective?
7. BioSphere Medical's HepaSphere Microspheres Safely Deliver Doxorubicin in Liver Cancer Chemoembolization Therapy -- Study Presented at SIR
8. Researchers find new chemotherapy combination shows promise in endometrial cancer
9. Chemotherapy plus synthetic compound provides potent anti-tumor effect in pancreatic cancers
10. Recommended Dental Care for Chemotherapy Patients -- Advice from Steven McConnell, DDS
11. Chemo May Boost Survival After Lung Cancer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemo May Raise Risk of Falls in Breast Cancer Survivors
(Date:12/9/2016)... NY (PRWEB) , ... December 09, 2016 , ... ... and Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits ... and the District of Columbia as an education tool in the war against teen ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... Pierre Hotel in New York, NY, on December 3rd, to benefit Holy Name ... attended the annual event, which raised over $1 million - the largest event ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Quality Insights beginning January 1, 2017. The name change aligns the entire ... measuring and improving health care quality. , “We are very proud of the ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... DIEGO , Dec. 9, 2016 aTyr Pharma, Inc. ... discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, ... at the upcoming BMO Prescriptions for Success Healthcare Conference at the ... on Wednesday, December 14, 2016, at 4:20 p.m. ET. ... ...
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences Ltd. ... biopharmaceutical company focused on the treatment of dementia, ... from a Phase 2b trial evaluating treatment with ... compared with donepezil plus placebo in people with ... addition of intepirdine to treatment was associated with ...
(Date:12/8/2016)... , Dec. 8, 2016 Australia Glaucoma ... GlobalData,s new report, "Australia Glaucoma Surgery Devices ... on the Australia Glaucoma Surgery Devices market. The ... volume (in units) and average prices (USD) within ... report also provides company shares and distribution shares ...
Breaking Medicine Technology: